AddLife AB (CHIX:ALIFBS) Long-Term Debt: kr0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ALIFBS AddLife AB CHIX:ALIFBS
86 GF Score
Price kr159.05
GF Value kr147.90
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is AddLife AB Long-Term Debt?

AddLife AB CHIX:ALIFBS 86 Long-Term Debt is kr0 Mil as of Jun. 2026. GuruFocus rates CHIX:ALIFBS with a GF Score™ of 86/100 and a GF Value™ of kr147.90 (Fairly Valued). The stock has 5 warning signs investors should review.

AddLife AB's Long-Term Debt for the quarter that ended in Jun. 2026 was kr0 Mil.

AddLife AB's quarterly Long-Term Debt declined from Dec. 2025 (kr2,490 Mil) to Mar. 2026 (kr0 Mil) but then stayed the same from Mar. 2026 (kr0 Mil) to Jun. 2026 (kr0 Mil).

AddLife AB's annual Long-Term Debt increased from Dec. 2023 (kr2,539 Mil) to Dec. 2024 (kr3,738 Mil) but then declined from Dec. 2024 (kr3,738 Mil) to Dec. 2025 (kr2,490 Mil).

AddLife AB  (CHIX:ALIFBs) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

AddLife AB Long-Term Debt Related Terms

AddLife AB Long-Term Debt Historical Data

* Premium members only.

The historical data trend for AddLife AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AddLife AB Long-Term Debt Chart

AddLife AB Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 564.00 2,744.00 2,539.00 3,738.00 2,490.00

AddLife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 2,490.00 0.00 0.00
CHIX:ALIFBS
86GF Score
AddLife AB CHIX:ALIFBS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of kr0 Mil mean?
AddLife AB (CHIX:ALIFBS) has a Long-Term Debt of kr0 Mil as of Jun. 2026.
Is AddLife AB's Long-Term Debt too high?
AddLife AB's current Long-Term Debt is kr0 Mil. Overall, AddLife AB has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Long-Term Debt compare to ISRG and BDX?
AddLife AB's Long-Term Debt of kr0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. AddLife AB's current Long-Term Debt is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
Based on GuruFocus' analysis, AddLife AB (CHIX:ALIFBS) is currently considered Fairly Valued. The stock's GF Value™ is kr147.90, compared to a current price of kr159.05 — trading 7.5% above its estimated fair value. The current Long-Term Debt is kr0 Mil. AddLife AB's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For AddLife AB (CHIX:ALIFBS), the current Long-Term Debt is kr0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AddLife AB (CHIX:ALIFBS) Overvalued in 2026?

Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued. The current stock price of kr159.05 is trading 7.5% above its estimated GF Value™ of kr147.90. GuruFocus considers AddLife AB to be Fairly Valued.

Key valuation signals for CHIX:ALIFBS:

  • Long-Term Debt: kr0 Mil
  • GF Value™: kr147.90 vs. price of kr159.05 (7.5% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ALIFBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AddLife AB Business Description

Address Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
86GF Score

Get the complete analysis for CHIX:ALIFBS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr159.05
Price
kr147.90
GF Value